V Traina-Dorge

Summary

Affiliation: Tulane University
Country: USA

Publications

  1. ncbi request reprint Robust pro-inflammatory and lesser anti-inflammatory immune responses during primary simian varicella virus infection and reactivation in rhesus macaques
    Vicki Traina-Dorge
    Division of Microbiology, Tulane National Primate Research Center, Tulane University, 18703 Three Rivers Road, Covington, LA, 70433, USA
    J Neurovirol 20:526-30. 2014
  2. pmc Increased cellular immune responses and CD4+ T-cell proliferation correlate with reduced plasma viral load in SIV challenged recombinant simian varicella virus - simian immunodeficiency virus (rSVV-SIV) vaccinated rhesus macaques
    Bapi Pahar
    Division of Microbiology, Tulane National Primate Research Center, Tulane University School of Medicine, Covington, LA 70433, USA
    Virol J 9:160. 2012
  3. pmc Molecular epidemiology of simian T-cell lymphotropic virus type 1 in wild and captive sooty mangabeys
    Vicki L Traina-Dorge
    Division of Microbiology and Immunology, Tulane National Primate Research Center, 18703 Three Rivers Rd, Covington, LA 70433, USA
    J Virol 79:2541-8. 2005
  4. ncbi request reprint Human T cell leukemia virus type 1 up-regulation after simian immunodeficiency virus-1 coinfection in the nonhuman primate
    Vicki L Traina-Dorge
    Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70433, USA
    J Infect Dis 195:562-71. 2007
  5. pmc Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques
    V Traina-Dorge
    Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70433, United States
    Vaccine 28:6483-90. 2010
  6. ncbi request reprint Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection
    Mark A Beilke
    Tulane University Health Sciences Center School of Medicine, New Orleans, Louisiana, USA
    Clin Infect Dis 44:1229-34. 2007

Detail Information

Publications6

  1. ncbi request reprint Robust pro-inflammatory and lesser anti-inflammatory immune responses during primary simian varicella virus infection and reactivation in rhesus macaques
    Vicki Traina-Dorge
    Division of Microbiology, Tulane National Primate Research Center, Tulane University, 18703 Three Rivers Road, Covington, LA, 70433, USA
    J Neurovirol 20:526-30. 2014
    ..Characterization of cytokine, chemokine and growth factor responses during different stages of varicella virus infection will facilitate immunotherapeutic and vaccine strategies. ..
  2. pmc Increased cellular immune responses and CD4+ T-cell proliferation correlate with reduced plasma viral load in SIV challenged recombinant simian varicella virus - simian immunodeficiency virus (rSVV-SIV) vaccinated rhesus macaques
    Bapi Pahar
    Division of Microbiology, Tulane National Primate Research Center, Tulane University School of Medicine, Covington, LA 70433, USA
    Virol J 9:160. 2012
    ....
  3. pmc Molecular epidemiology of simian T-cell lymphotropic virus type 1 in wild and captive sooty mangabeys
    Vicki L Traina-Dorge
    Division of Microbiology and Immunology, Tulane National Primate Research Center, 18703 Three Rivers Rd, Covington, LA 70433, USA
    J Virol 79:2541-8. 2005
    ....
  4. ncbi request reprint Human T cell leukemia virus type 1 up-regulation after simian immunodeficiency virus-1 coinfection in the nonhuman primate
    Vicki L Traina-Dorge
    Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70433, USA
    J Infect Dis 195:562-71. 2007
    ..We conclude that SIV may have the potential to up-regulate HTLV-1 and disease expression...
  5. pmc Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques
    V Traina-Dorge
    Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70433, United States
    Vaccine 28:6483-90. 2010
    ....
  6. ncbi request reprint Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection
    Mark A Beilke
    Tulane University Health Sciences Center School of Medicine, New Orleans, Louisiana, USA
    Clin Infect Dis 44:1229-34. 2007
    ..The long-term effects of coinfection are unknown, and little information exists regarding how levels of HTLV-1/2 viral burden are affected by antiretroviral medications...